Here's a look at the most common OSHA concerns in greenhouse and nursery environments and how to address them.

"In most U.S. states, flashing your headlights is legal. Courts have generally ruled it as a form of expression protected under the First Amendment, though specific regulations can vary by location," ...

John Crane, a global leader in flow-control technologies and an innovator in solutions for rotating equipment, and a business of Smiths Group plc ...

CISA and international partners issued new guidance on securing AI in operational technology, warning of OT risks and urging ...

OSHA closed two investigations regarding the construction company and contractor when a crane collapsed in Merritt Island in June, claiming no violations were found. Republican warns Trump admin move ...

MERRITT ISLAND, Fla. — The Occupational Safety and Health Administration (OSHA) investigated the crane company and the general contractor overseeing the site. Both investigations concluded without any ...

GREENVILLE, N.C. (WNCT) — The NCDOT is installing a new HAWK safety signal at the crosswalk on 10th St. near the ECU Student Center. The new High-Intensity Activated Crosswalk safety signal will ...

Bimekizumab's safety profile was evaluated using FAERS data, identifying 2780 reports and 70 significant safety signals. The study found 29 previously unreported adverse events, including cellulitis ...

A construction worker building a concrete wall at SpaceX’s Starbase site in November was crushed by a large metal support that fell from a crane, and the Occupational Safety and Health Administration ...

Map showing the scope of intersection work and road widening on Route 106 in Loudon. Credit: COURTESY / New Hampshire Department of Transportation Sign up for the Concord Monitor's morning newsletter ...

New York City building officials are enforcing new safety regulations for cranes after determining the cause of a partial crane collapse that injured several people in Midtown in 2023. Diesel-powered ...

Hypersensitivity reactions in a mouse model prompted the agency to suspend Denali’s planned Phase I development for DNL952 for Pompe disease. The FDA has placed a clinical hold on Denali Therapeutics’ ...